HEALTH LAW SECTION BLOG

Other tags used on this blog:

• ACA (1)
• aca (1)
• access (5)
• accreditation standards (1)
• ACLU (3)
• ACO (2)
• admission agreement (1)
• adult homes (1)
• advanced therapy medicinal products (1)
• adverse events (8)
• adverse selection (1)
• advisory opinion (1)
• AERs (4)
• aetna (4)
• affordable care act (2)
• age discrimination (1)
• AHRQ (5)
• AIDS (1)
• alternative dispute resolution (1)
• AMA (3)
• ambulance (1)
• ambulatory surgery center (1)
• animals in research (2)
• anti-kickback (4)
• antitrust (2)
• applied gene therapy (1)
• assisted living facilites (2)
• ATMPs (1)
• attorney general (13)
• audit (9)
• authentication (1)
• autopsy (1)
• AWP (3)
• bankruptcy (4)
• behavioral science (1)
• benefit mandates (3)
• benefits (1)
• Berger commission (10)
• bioethics (3)
• biologics (1)
• biomarkers (4)
• biomedical informatics (1)
• biomedical technology (3)
• biometrics (1)
• biosafety (1)
• biosimilars (1)
• blogging (9)
• blood donors (2)
• blood screening tests (1)
• body tissues (1)
• botanical preparation (1)
• BPA (2)
• BRCA (4)
• breast cancer (1)
• brokers (2)
• Brookhaven (1)
• budget (11)
• cancer (8)
• carbon pollution (1)
• care management (1)
• CBER (2)
• CBO (2)
• CDC (1)
• CDER (6)
• CDPHP (1)
• CDT (2)
• cell therapy (2)
• CERHR (1)
• charitable purpose (1)
• child health plus (2)
• children (3)
• China (4)
• chronic care coordination (1)
• chronic disease (1)
• church and state (1)
• cigna (1)
• CIPIH (2)
• Citizen Media Law Project (1)
• claims (1)
• CLE (1)
• climate change (1)
• clinical laboratories (2)
• clinical practice (1)
• clinical trials (21)
• cloning (2)
• CMS (2)
• co-branding (1)
• COBRA (1)
• COI (2)
• collaboration (1)
• collective bargaining (1)
• combinatorial chemistry (1)
• Commonwealth Fund (1)
• comparative effectiveness (2)
• comparative law (1)
• competitiveness (1)
• compliance plans (1)
• compound authorizations (1)
• compound libraries (1)
• comptroller (1)
• CON (2)
• concierge medicine (1)
• conflicts of interest (3)
• conscience clause (1)
• Constitutional Law (1)
• construction (2)
• consumer (4)
• consumer health information (4)
• continuum (1)
• conversion (3)
• COPS (1)
• corporate practice of medicine (1)
• counterfeits (1)
• court administration and law (1)
• criminal charges (12)
• cuomo (14)
• cyber vocabulary (1)
• daines (2)
• data breach (7)
• data protection (4)
• database (5)
• DDMAC (1)
• death rates (1)
• diagnosis (1)
• dietary science and health relations (1)
• digital doctor-rural (1)
• digital technology (1)
• Dipnote (1)
• DNA (2)
• doctors across new york (2)
• DOH (17)
• domestic partner (3)
• donor eligibility/ testing (1)
• dose registry (1)
• downtown (1)
• drug development (4)
• drug discovery (4)
• drug disposal (1)
• drug labels (4)
• drug prescribing practices (2)
• drug price reports (1)
• drug product life cycles (1)
• drug production capability (1)
• drug promotions violations (1)
• drug risk evaluation and mitigation strategy (3)
• drug safety (13)
• Drug Safety Communication (1)
• drug shortage (1)
• drug side effects (2)
• drug/biologics products safety (1)
• e-health (3)
• e-prescribing (2)
• EIN (1)
• electronic health records (12)
• electronic medical records (16)
• emergency care (4)
• emergency department (4)
• empire (2)
• employer identification numbers (1)
• EMR (5)
• EMS (1)
• energy (1)
• environmental health (3)
• EPA (1)
• EPHT (1)
• epidemiology (1)
• epigenetics (1)
• ERISA (2)
• errors (3)
• ESSCB (8)
• ESSCB Ethics Committee (2)
• ethics (12)
• ethnobotanical preparation (1)
• EU's EMA (2)
• Europe (2)
• European Food Safety Authority (1)
• evidence-based medicine (3)
• exclusion (2)
• executive compensation (1)
• exempt organizations (5)
• expansion (2)
• external appeal (1)
• extrapolation (1)
• false claims (6)
• family health care decisions act (3)
• family law (1)
• family planning (4)
• FDA (19)
• FDA employees/MAPP (1)
• FDA risk/benefit communications (1)
• FDA Science board (1)
• FDA's quality by design (1)
• FDA's weekly issues column (1)
• FDAAA (11)
• federal civil litigation (1)
• fertility (2)
• FHCDA (3)
• fines (7)
• First Amendment (1)
• food safety (4)
• food stamps (1)
• food/diet-related diseases (1)
• foundations (1)
• fraud (33)
• FTC (3)
• full disclosure/caveat emptor (1)
• fundraising (1)
• gamete donation (2)
• GAO (1)
• gene patents (2)
• gene therapy (4)
• generally accepted professional practices (1)
• generics (1)
• genetic information (6)
• genetic terms glossary (1)
• genetic testing (6)
• genomic medicine (5)
• genomic research (1)
• Geron's regenerative product pipeline (1)
• GFP (1)
• GHI/HIP (4)
• global academic-industry collaboration (1)
• global health (8)
• global publications benchmarking (1)
• globalized economy (1)
• GLP (1)
• GME (3)
• GMP (1)
• Good Clinical Practice (1)
• google (2)
• grant (6)
• H1N1 (6)
• HANYS (2)
• HCAHPS (1)
• HCFAC (1)
• HCLD (1)
• HCRA (2)
• HEAL grants (2)
• health care costs (6)
• health care disparities (2)
• health care interventions (1)
• health care reform (30)
• health home (1)
• Health Indicators Warehouse (1)
• health information (4)
• health information exchange (2)
• health insurance (11)
• health IT (2)
• health maintenance organizations (2)
• health product development (1)
• health research science (1)
• Health Research Science Board (1)
• health research services (2)
• health researchers (1)
• health sciences (1)
• health services research (2)
• healthcare and life sciences (1)
• HealthNet (1)
• healthnow (2)
• healthy ny (2)
• HESC (5)
• HHC (3)
• high throughput screening (1)
• HIPAA (26)
• HIPAA security (2)
• HITECH (1)
• HIV (2)
• HMOs (2)
• home health (5)
• hospital closings (25)
• hospital-patient relationship (1)
• hospitals (68)
• HSCI (1)
• human blood transfusions (1)
• human genome research (1)
• human rights (1)
• human subject protection (6)
• hypertension (1)
• I-STOP (1)
• Iceland (1)
• ICH (4)
• improved medical treatments (1)
• incident reporting (1)
• indictment (1)
• individual mandate (1)
• individualized medicine (1)
• infection (2)
• infection rates (2)
• infectious diseases (1)
• influenza (1)
• information security (9)
• information technology (18)
• informed consent (8)
• ingenix (6)
• innovation ecosystem (1)
• innovation for health outcomes (1)
• innovation life sciences (9)
• innovative medical technologies (1)
• Inspector general (3)
• insurance (7)
• insurance department (27)
• int'l FDA pilot programs (1)
• international DNA banks (1)
• international genetic laws (1)
• international harmonization (4)
• international harmonization: pharma regs (2)
• international health affairs (4)
• international health policy perspectives (7)
• international law (3)
• international pharma industry (1)
• international research standards (3)
• international scientific collaboration (5)
• Internet freedom (1)
• internet pharmacy (1)
• Internet speech (1)
• IOM (1)
• IP (1)
• iPS cells (2)
• iPS Center NIH (1)
• IRB (2)
• IRBs (1)
• IRS (5)
• iSCNT (1)
• ISSCR (2)
• Japan (2)
• joint commission (1)
• jonathan's law (1)
• judiciary (1)
• kendra's law (1)
• law blog ideas (8)
• law blog related (3)
• law blogging (3)
• laws (3)
• leapfrog group (2)
• legal practice (2)
• legal profession (2)
• legal resources (6)
• legal service business resources (1)
• legislation (8)
• life sciences (2)
• long term care (1)
• malpractice (5)
• mammograms (1)
• managed care (9)
• mandates (2)
• marijuana (2)
• Markle Connecting for Health (1)
• massachusetts (11)
• maternity (2)
• MDUFMA (2)
• mediation (1)
• medicaid (45)
• medicaid recovery audit program (1)
• medical diagnostics (1)
• medical error (1)
• medical home (3)
• medical imaging safety (1)
• medical information (1)
• medical liability reforms (1)
• medical malpractice (1)
• medical records (3)
• medical research (4)
• medical science (1)
• medically necessary drug products shortages (1)
• medicare (18)
• medicare advantage (1)
• Medication Guides (1)
• MediSys (1)
• meetings (2)
• Memorial Sloan-Kettering Cancer Center (2)
• mental health (10)
• mercy medical center (1)
• mergers (7)
• MFCU (2)
• michelle's law (1)
• microsoft (2)
• midwifery (1)
• molecular tests (1)
• montefiore (1)
• mount sinai (1)
• MSSNY (1)
• Myriad gene patents (1)
• nanobioscience (1)
• nanobusiness (1)
• nanotechnology (2)
• National Academies (1)
• National Health and Nutrition Survey (1)
• National Organ Transplantation Act (1)
• natural products in chemistry (1)
• natural/unatural in biology (1)
• NCI (1)
• NCRP (1)
• NCVIA (1)
• near-misses (1)
• never events (2)
• new therapies (1)
• New York medical research institutions (5)
• new york-presbyterian (2)
• newborn screening program (1)
• NHGRI (1)
• Nigeria (1)
• NIH Challenge Grants in Health and Science Research (1)
• NIH NCATS (1)
• NIH NHGRI (1)
• NIH OTT model agreements (1)
• NIH stem cell research (1)
• NIH's CTSA (1)
• NIH's Feedback blog (1)
• non-network care (1)
• nonclinical abuse liability (1)
• nonclinical safety/efficacy studies (1)
• not HIPAA (1)
• not-for-profit (7)
• notice (2)
• nursing (9)
• nursing homes (11)
• nutrition (3)
• NYeC (1)
• NYHISPC (1)
• NYLJ health article (11)
• NYS ESD (1)
• NYSBA blogs (1)
• NYSTEM (20)
• obesity (2)
• observation units (1)
• off-label drug uses (2)
• Office of Health Information Technology Transformation (1)
• OHITT (1)
• OHRP (2)
• OIG (8)
• OMH (1)
• OMIG (9)
• on-line collaboration (1)
• on-line medical records (1)
• on-line purchase of medicine (1)
• oocyte donation risks (1)
• OPASI (1)
• organ donation (2)
• organ donors (1)
• organ procurement (3)
• organ procurement organization (1)
• organ transplants-financial incentives (1)
• orphan drugs (1)
• orszag (1)
• out-of-network care (5)
• outpatient clinic (1)
• overpayment (4)
• oversight (2)
• overtime (1)
• P2P (1)
• P4P (1)
• pandemic (1)
• paradigm shift (T. Kuhn) (1)
• paradigms (1)
• Parkinson's disease (1)
• partnership for coverage (4)
• patent case pilot project (1)
• paterson (5)
• patient abuse (1)
• patient de-identified data (1)
• patient informed consent (1)
• patient medical imaging card (1)
• patient rights (2)
• patient safety (2)
• pay-for-performance (3)
• payment (2)
• payors (1)
• PCMH (3)
• PDUFA (2)
• pediatric population studies (1)
• pediatric research (1)
• peer review (7)
• personal health record (4)
• Personal Health Records (1)
• personalized medicine (7)
• personalized treatment (1)
• personally identifiable data (1)
• pharmacogenomics (1)
• pharmacy (6)
• PHI (1)
• PHR (2)
• PHRs (2)
• physician self-referral (7)
• physician shortage (4)
• placebos (1)
• pluripotent stem cells (1)
• policy (1)
• policy and law (1)
• policy ideas (4)
• policy settings (1)
• post approval study (1)
• postmarketing drug safety (1)
• postmarketing risk surveillance (1)
• poverty (2)
• PPACA (3)
• pre-market approval (1)
• preemption (1)
• preet bharara (1)
• presciption drugs (3)
• prescription (2)
• prescription drugs (14)
• Presidential Proclamation (1)
• pressure ulcer (1)
• preventive care (1)
• primary care (5)
• principles-based regulation (1)
• prior approval (1)
• privacy (27)
• prompt pay (3)
• property taxes (1)
• protein mapping (1)
• proton beam therapy (1)
• psychoactive drugs (1)
• public access (1)
• public health (3)
• public health council (2)
• public health surveillance (5)
• public private partnerships (9)
• public-private collaborative (1)
• PUBPAT (3)
• punitive damages (1)
• qarr (2)
• quality (15)
• quality assurance (1)
• R&D (2)
• rankings (13)
• rare diseases (1)
• ratios (1)
• rDNA research activity (1)
• readmissions (1)
• Reagan-Udall (1)
• records (1)
• recoupment (2)
• Redbook 2000 (1)
• redi-clinics (6)
• reform (14)
• regenerative medicine (7)
• regulations (8)
• regulatory processes (1)
• Regulatory Science Program NIH (1)
• reimbursement (5)
• religious employers (2)
• REMS (2)
• REMs (1)
• reporting (1)
• reports (1)
• reproduction toxicity studies (1)
• reproductive biology (1)
• research (2)
• research board governance (3)
• research consortium (1)
• research output (1)
• research resources (4)
• research subjects (1)
• results-oriented regulatory processes (1)
• retail clinics (7)
• reviews (2)
• RHIO (4)
• risk/benefit assessment research (1)
• rural physicians (1)
• Safe Use Initiative (1)
• SCHIP (1)
• science and statistics in law (1)
• science in law (13)
• science/philosophy (2)
• scientific integrity (6)
• SCNT (1)
• screening (4)
• security breach (2)
• serbaroli (16)
• shared savings (1)
• sheehan (2)
• simulated human browsing (1)
• single payer (2)
• spinal cord injury (1)
• spitzer (6)
• st. francis (1)
• st. vincent's (12)
• standardized measures (2)
• standards (6)
• standarized measures (1)
• stark (7)
• state initiatives (5)
• stem cells (35)
• subpoenas (1)
• subsidies (1)
• substance use disorder (1)
• Supreme Court (7)
• surcharges (1)
• swidler (1)
• synthetic biology (1)
• taxes (6)
• technology transfer (1)
• telemedicine (1)
• therapeutic cloning techniques (1)
• therapeutic development (1)
• tissue (2)
• tissue banking (1)
• torts (1)
• toxic chemical exposure (1)
• toxicology (1)
• transparency (15)
• twitter (1)
• UCR (2)
• UIDP (1)
• UK (2)
• uninsured (7)
• unions (6)
• unitedhealth (2)
• universal coverage (13)
• UNOS (1)
• upstate (3)
• US-China PPP (1)
• USITC global healthcare services biotech SMEs (1)
• usual and customary (6)
• vaccines (13)
• virus (1)
• wal-mart (1)
• Web of Science (1)
• web scraping (1)
• webcast (1)
• wellcare (1)
• wellness (2)
• wellpoint (1)
• whistleblower (1)
• World Health Assembly (1)
• young lawyers (1)